Delcath Systems, Inc.
DCTH
$12.98
$0.413.26%
| Weiss Ratings | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.98 | |||
| Price History | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.02% | |||
| 30-Day Total Return | -17.48% | |||
| 60-Day Total Return | 2.45% | |||
| 90-Day Total Return | 30.98% | |||
| Year to Date Total Return | 2.93% | |||
| 1-Year Total Return | 176.17% | |||
| 2-Year Total Return | 119.26% | |||
| 3-Year Total Return | 98.17% | |||
| 5-Year Total Return | 23.62% | |||
| 52-Week High % Change | -25.93% | |||
| 52-Week Low % Change | 195.07% | |||
| Price | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $16.97 | |||
| 52-Week Low Price | $4.26 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Feb 07, 2025 | |||
| Valuation | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 419.88M | |||
| Enterprise Value | 367.68M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.98 | |||
| Earnings Per Share Growth | -67.14% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 10.82 | |||
| Price/Book (Q) | 6.05 | |||
| Enterprise Value/Revenue (TTM) | 9.88 | |||
| Price | $12.98 | |||
| Enterprise Value/EBITDA (TTM) | -29.95 | |||
| Enterprise Value/EBIT | -29.63 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 32.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212-489-2100 | |||
| Address | 566 Queensbury Avenue New York, NY 12804 | |||
| Website | www.delcath.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -33.35% | |||
| Profit Margin | -70.92% | |||
| Management Effectiveness | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -13.47% | |||
| Return on Equity | -- | |||
| Income Statement | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 37.21M | |||
| Total Revenue (TTM) | 37.21M | |||
| Revenue Per Share | $1.16 | |||
| Gross Profit (TTM) | 31.02M | |||
| EBITDA (TTM) | -12.28M | |||
| EBIT (TTM) | -12.41M | |||
| Net Income (TTM) | -26.39M | |||
| Net Income Avl. to Common (TTM) | -26.39M | |||
| Total Revenue Growth (Q YOY) | 2,701.48% | |||
| Earnings Growth (Q YOY) | 69.49% | |||
| EPS Diluted (TTM) | -0.98 | |||
| EPS Diluted Growth (Q YOY) | 77.90% | |||
| Balance Sheet | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 53.23M | |||
| Cash Per Share (Q) | $1.66 | |||
| Total Current Assets (Q) | 73.76M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 68.75M | |||
| Current Ratio (Q) | 12.005 | |||
| Book Value Per Share (Q) | $2.08 | |||
| Total Assets (Q) | 76.59M | |||
| Total Current Liabilities (Q) | 6.14M | |||
| Total Debt (Q) | 1.04M | |||
| Total Liabilities (Q) | 7.84M | |||
| Total Common Equity (Q) | 68.75M | |||
| Cash Flow | DCTH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -981.00K | |||
| Cash from Financing (TTM) | 39.41M | |||
| Net Change in Cash (TTM) | 19.72M | |||
| Levered Free Cash Flow (TTM) | -14.08M | |||
| Cash from Operations (TTM) | -18.68M | |||
